Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer
Cancer Cell · 2026
DOI: 10.1016/j.ccell.2026.05.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Rong Tang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China; Department of Oncology, Shanghai Medical College, …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Education Commission, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Traditional bulk-level transcriptomic sequencing cannot link cell type-specific gene expression to patient survival. In this study, we integrate single-nucleus RNA-seq and longitudinal data from 152 patients with pancreatic ductal adenocarcinoma (PDAC), profiling 1.2 million cells to construct a prognostic map connecting cell type-resolved gene expression with overall survival. Using a single-cell-resolved spatial transcriptomic platform, we further analyze 3.1 million cells and correlate their spatial distribution with therapeutic response. To empower the translational research community, we develop ctPANDA, an interactive platform offering cell-type-level prognostic insights. This atlas identifies PLOD2 as a promising target, with elevated expression predicting poorer outcomes across eight cell types. We have developed a proof-of-concept compound that can effectively degrade PLOD2 and inhibit PDAC progression in vivo. Collectively, this study advances the prognostic analysis from bulk-level to cell-type resolution, establishing a framework linking gene expression to clinical outcomes and providing actionable insights for target discovery and precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200030, China.
- Shanghai Pancreatic Cancer Institute, Shanghai 200032, China; Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai 200032, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200030, China.
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China; Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.
- Shanghai Pancreatic Cancer Institute, Shanghai 200032, China.
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China.
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Education Commission
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Tang, R., Jin, L., Chen, C., Liao, Y., Li, D., Li, Y., Chen, Y., Liu, Y., Du, Q., Rong, Z., Chen, J., Lei, Y., Wu, Z., Tan, Z., Wang, Y., Wang, H., Xu, J., Wang, W., Shi, S., & Yu, X. (2026). Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.05.012
Vancouver
Tang R, Jin L, Chen C, Liao Y, Li D, Li Y, et al. Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.05.012
BibTeX
@article{Tang2026,
author = {Tang, Rong and Jin, Liquan and Chen, Chen and Liao, Yingna and Li, Dingru and Li, Yangyi and Chen, Yueyue and Liu, Yuan and Du, Qiong and Rong, Zeyin and Chen, Jiaoshun and Lei, Yubin and Wu, Zijian and Tan, Zhen and Wang, Yufeng and Wang, Haoyu and Xu, Jin and Wang, Wei and Shi, Si and Yu, Xianjun},
title = {Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2026.05.012}
}
EUVIMED